Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145301
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2005-09-01
Brief Title:
52 Week International Multi-center Randomized Double-blind Double-dummy Parallel-group Clinical Trial to Compare Retention on Treatment Safety Tolerability Efficacy of Lumiracoxib 100 mg od Lumiracoxib 100 mg Bid Celecoxib 200 mg od in Pts With Primary OA of Hip Knee Hand or Spine
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2005-11
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-09-01
First Submit QC Date:
September 1 2005
Study First Post Date:
2005-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-18
Last Update Post Date:
2012-05-21
Last Update Post Date Type:
ESTIMATED